Byetta (exenatide) / AstraZeneca  >>  Phase 3
Welcome,         Profile    Billing    Logout  

3 Trials

   Remove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Byetta (exenatide) / AstraZeneca
NCT00679042: Islet Transplantation in Type 1 Diabetic Patients Using the University of Illinois at Chicago (UIC) Protocol

Active, not recruiting
3
21
US
Islets of Langerhans transplantation, Islets of Langerhan (Islets), Basiliximab (Simulect®), Tacrolimus (Prograf®), Sirolimus (Rapamune®), Etanercept(Enbrel®), Exenatide (Byetta®)
CellTrans Inc.
Type 1 Diabetes Mellitus
07/17
06/26
DFBT-JY09-DM-301, NCT06254014: A Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Placebo in T2DM Patients

Not yet recruiting
3
270
RoW
Exendin-4 Fc fusion protein injection, JY09(1.2mg), JY09(2.4mg), Placebo, Injection mimetic
Beijing Dongfang Biotech Co., Ltd.
Type 2 Diabetes Mellitus
04/25
12/25
DFBT-JY09-DM-302, NCT06257966: A Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Dulaglutide in Combination Therapy Diabetes Mellitus Type 2 Patients With Metformin

Not yet recruiting
3
600
RoW
Exendin-4 Fc fusion protein injection(1.2mg）, JY09(1.2mg), Exendin-4 Fc fusion protein injection（2.4mg）, JY09(2.4mg), Dulaglutide, Metformin
Beijing Dongfang Biotech Co., Ltd.
Type2 Diabetes Mellitus
04/25
12/25

Download Options